TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2019-08-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-005793 |
| 2019-07-0906:57 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-004898 |
| 2019-06-2116:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001387131-19-004542 |
| 2019-06-1014:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-004327 |
| 2019-06-0707:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-004260 |
| 2019-05-1507:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-003624 |
| 2019-05-0817:02 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001387131-19-003457 |
| 2019-05-0616:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-003362 |
| 2019-04-3021:04 ET | DEF 14A | Proxy statementPeriod 2019-06-20 | 0001387131-19-003116 |
| 2019-04-2516:33 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-002928 |
| 2019-04-1716:08 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-002719 |
| 2019-04-0807:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-002554 |
| 2019-03-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-001840 |
| 2019-02-2718:45 ET | 10-K | Annual reportPeriod 2018-12-31 | 0001387131-19-001471 |
| 2019-02-2116:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-001384 |
| 2019-02-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-000777 |
| 2019-01-0919:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-000127 |
| 2019-01-0807:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-19-000111 |
| 2018-12-1806:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-006811 |
| 2018-11-2706:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-006378 |
| 2018-11-1306:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-006073 |
| 2018-11-0807:01 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001387131-18-005976 |
| 2018-11-0716:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-005954 |
| 2018-10-2906:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-005702 |
| 2018-10-0207:00 ET | 8-K | 7.01 Regulation FD disclosure | 0001387131-18-005143 |
| 2018-09-2716:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-005012 |
| 2018-09-2407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-004910 |
| 2018-09-0507:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-004474 |
| 2018-08-2106:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-004119 |
| 2018-08-1306:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-003883 |
| 2018-08-0309:28 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-18-237291 |
| 2018-07-3006:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-003402 |
| 2018-07-3006:04 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001387131-18-003401 |
| 2018-06-2617:00 ET | 8-K | 5.07 Shareholder vote results | 0001387131-18-002850 |
| 2018-06-0716:05 ET | 8-K | 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-002560 |
| 2018-06-0409:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-002489 |
| 2018-05-3006:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-002408 |
| 2018-05-0716:35 ET | 10-Q | Quarterly reportPeriod 2018-03-31 | 0001387131-18-001945 |
| 2018-05-0316:11 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-001909 |
| 2018-04-2717:04 ET | DEF 14A | Proxy statementPeriod 2018-06-25 | 0001387131-18-001815 |
| 2018-04-1620:06 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-18-001600 |
| 2018-04-1106:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-001522 |
| 2018-04-0207:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-001328 |
| 2018-03-1207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-001037 |
| 2018-03-0817:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-001009 |
| 2018-02-2317:00 ET | 10-K | Annual reportPeriod 2017-12-31 | 0001387131-18-000776 |
| 2018-02-2016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-18-000732 |
| 2018-02-1417:23 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-18-000665 |
| 2018-01-0906:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-18-000105 |
| 2017-12-1916:44 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-17-005903 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.